Merit Medical Systems Analyst Price Targets

Ganancias: Los beneficios de Q3 2026 se publicaron el jue oct 29th, después del cierre del mercado

Conferencia telefónica: La conferencia telefónica más reciente comenzó a las 4:30 p. m., hace 2 días

Fusiones y adquisiciones: Solo Pace, Inc was acquired by Merit Medical Systems (MMSI) on Thursday, October 29, 2026 for $45M

Merit Medical Systems Analyst Price Targets

Wall Street analyst price targets and consensus rating for Merit Medical Systems (MMSI).

Price Target Range — 11 Quarters

Analyst Consensus — 10 Analysts

8Buy

2Hold

Consensus RatingOutperform# Analysts10Avg. Consensus PT$105Upside to Avg. PT+21.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 30, 2026	Canaccord Genuity	Jon Young	PT Raise	Buy	$94→$121
Oct 30, 2026	JP Morgan	Robbie Marcus	PT Raise	Overweight	$95→$110
Oct 30, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Equal-Weight	$83→$92
Oct 30, 2026	Needham	Mike Matson	PT Raise	Buy	$101→$106
Oct 30, 2026	BTIG	Sam Eiber	PT Raise	Buy	$105→$110
Oct 27, 2026	Freedom Capital Markets	Keith Hinton	Initiate	Hold	$90
Sep 29, 2026	Needham	Mike Matson	Maintained	Buy	$101
Aug 13, 2026	B of A Securities	Craig Bijou	PT Raise	Neutral	$92→$97
Aug 11, 2026	BTIG	Sam Eiber	Maintained	Buy	$105
Aug 3, 2026	Canaccord Genuity	Jon Young	PT Raise	Buy	$85→$94
Jul 31, 2026	JP Morgan	Robbie Marcus	PT Raise	Overweight	$77→$95
Jul 31, 2026	Piper Sandler	Jason Bednar	PT Raise	Overweight	$96→$106
Jul 31, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Equal-Weight	$74→$83
Jul 31, 2026	Needham	Mike Matson	PT Raise	Buy	$90→$101
Jul 31, 2026	BTIG	Sam Eiber	PT Raise	Buy	$100→$105
May 1, 2026	Canaccord Genuity	Jon Young	PT Cut	Buy	$90→$85
May 1, 2026	JP Morgan	Robbie Marcus	PT Cut	Overweight	$95→$77
May 1, 2026	Wells Fargo	Larry Biegelsen	PT Cut	Equal-Weight	$78→$74
May 1, 2026	Needham	Mike Matson	PT Cut	Buy	$101→$90
Apr 20, 2026	Barrington Research	Michael Petusky	PT Cut	Outperform	$109→$107

Analyst Ratings News

PRO
Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $121

Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $94 to $121.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Merit Medical Systems, Raises Price Target to $110

JP Morgan analyst Robbie Marcus maintains Merit Medical Systems (NASDAQ:MMSI) with a Overweight and raises the price target from $95 to $110.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Equal-Weight on Merit Medical Systems, Raises Price Target to $92

Wells Fargo analyst Larry Biegelsen maintains Merit Medical Systems (NASDAQ:MMSI) with a Equal-Weight and raises the price target from $83 to $92.

Benzinga Newsdesk

These Analysts Boost Their Forecasts On Merit Medical Systems After Strong Q3 Results

Merit Medical beat Q3 estimates, raised FY2026 EPS guidance, narrowed sales outlook; analysts lifted price targets to $110 and $106.

Avi Kapoor

PRO
Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $106

Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $101 to $106.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on Merit Medical Systems, Raises Price Target to $110

BTIG analyst Sam Eiber maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $105 to $110.

Benzinga Newsdesk

Merit Medical Systems Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL